Thermo Fisher Scientific Inc.

    Jurisdiction
    United States
    LEI
    HCHV7422L5HDJZCRFL38
    ISIN
    US8835561023 (TMO)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    InsiderPie Expert Score
    62 / 100
    Even with peer group:
    62 / 100
    Fair value (Benjamin Graham formula)
    €396.47 14.7% overvalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. Read full profile

    Fundamentals

    Net revenue
    €37.01B
    Gross margin
    41.8%
    EBIT
    €6.35B
    EBIT margin
    17.2%
    Net income
    €5.65B
    Net margin
    15.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €39.28B +6.1% €7.79B +37.8%
    €41.73B +6.2% €8.46B +8.7%
    €44.05B +5.6% €9.20B +8.7%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.43
    Ex date
    Payment date
    Dividend payout ratio
    9.2%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Holmes Joseph R. VP & Chief Accounting Officer -385 $492.63 -$189.66K
    CASPER MARC N Chairman & CEO -10K $500.96 -$5.01M
    CASPER MARC N Chairman & CEO -496 $500.09 -$248.04K
    CASPER MARC N Chairman & CEO -18K $452.99 -$8.15M
    Pettiti Gianluca Executive Vice President -400 $479.98 -$191.99K

    Congress transactions

    Name Transaction date Value
    Val Hoyle September 12, 2025 $1.00K–$15.00K
    Val Hoyle September 12, 2025 $1.00K–$15.00K
    Kelly Morrison September 11, 2025 $16.00K–$65.00K
    Lisa McClain August 13, 2025 $1.00K–$15.00K
    Lisa McClain August 13, 2025 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    Al Gore 1.2M $592.42M -381K Sell
    James Anderson 509K $253.47M -29K Sell
    Peter Brown 155K $77.25M -26K Sell

    Earnings Calls

    Add to watchlist

    Notifications